NEWSROOM

BKIT

BioHemp International Provides Update on Current Status and its CBD Business Model

Aug 7, 2020

  NEW YORK, Oct. 24, 2019  -- – BioHemp International, Inc. (OTC: BKIT), (“Company”), a Company focused on consolidating distributors in the CBD industry, provides update on its current status, and outline of its future business model. The Company is pleased to announce it has retained two law firms to begin the process of bringing the company back to 'current' tier status with OTC Markets and the Securities and Exchange Commission (SEC). The Company is working diligently to provide all...

read more

BioHemp International, Inc. (OTC: BKIT) Acts in Response to SEC and OTC Trading Suspension

Aug 7, 2020

NEW YORK, New York--August 9, 2019 – – As previously disclosed on July 26th, 2019, the Securities and Exchange Commission ("Commission") announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the "Exchange Act"), of trading in the securities (the “Trading Suspension”) of BioHemp International (“BioHemp”) (OTC: BKIT) of New York, NY at 9:30 a.m. EDT on July 26, 2019, and terminating at 11:59 p.m. on August 8th, 2019.  BKIT is currently...

read more

Daniel Blum, CEO at BioHemp International (OTC: BKIT), discusses new position, CBD opportunities, and long-term company goals with Cannabis Hemp Wire

Aug 7, 2020

NEW YORK, New York--July 10th, 2019  -- – Cannabis Hemp Wire’s David Hempstein interviewed new BioHemp International (OTC: BKIT) CEO, Daniel Blum earlier this week to discuss new role, opportunities in the cannabinoid (CBD) market and both short and long term corporate goals. Mr. Blum joined BioHemp International, a Company focused on rolling up a distribution platform for CBD providers to become the leading consolidation force in the CBD industry, in June this year. Hempstein opened the...

read more

BioHemp International (OTC: BKIT) Clarifies Recent 8-K – No Material Change in Share Structure

Aug 7, 2020

NEW YORK, New York--July 15th, 2019 -- – BioHemp International, Inc. (OTC: BKIT) (the "Company”) clarifies that in the 8-K filed on July 12th, 2019, the 25 million shares issued as part of the transaction, was completed on March 9th, 2019. No additional shares have been issued, and there has not been a material change to the Company's issued and outstanding share structure which is 28,850,700 million shares outstanding reflected on the Company's OTC Markets profile, that has been verified by...

read more

Daniel Blum, CEO of BioHemp International (OTC: BKIT), discusses new position, CBD opportunities, and long-term company goals with Cannabis Hemp Wire

Aug 7, 2020

NEW YORK, New York--July 5th, 2019 -- – Cannabis Hemp Wire’s David Hempstein interviewed new BioHemp International (OTC: BKIT) CEO, Daniel Blum earlier this week to discuss his new role, opportunities in the cannabinoid (CBD) market and both short and long term corporate goals. Mr. Blum joined BioHemp International, the Company focused on becoming a platform to roll up CBD distributors to become the leading consolidation force in the industry. Hempstein opened the interview with a discussion...

read more

BioHemp International, Inc. (OTC: BKIT) Announces Deal to Private Label Water From American Premium Water Corporation (OTC: HIPH)

Aug 7, 2020

New Private Label Water To Be Sold Exclusively On BKIT’s Channels   NEW YORK, New York-July 8th, 2019 – – BioHemp International, Inc. (OTC: BKIT), (“Company”), a Company focused on consolidating the CBD industry, announces that it has entered an agreement with American Premium Water Corporation (OTC: HIPH) to white label cannabidiol (CBD) infused water utilizing HIPH’s proprietary Hydro Nano technology. The agreement provides exclusivity to the Company to utilize this technology and sell water...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »